Alerts will be sent to your verified email
Verify EmailTHYROCARE
Thyrocare Tech.
|
Vijaya Diagnostic
|
Metropolis Health.
|
|
---|---|---|---|
Operational Metrics
|
|||
Hospital Sector
|
|||
Number of Daily Patients - Diagnostic Centres
|
46.0 Ths | n/a | 35.89 Ths |
Number of Samples - Quarterly
|
5.9 Million | n/a | n/a |
No of Tests - Quarterly
|
46.9 Mn | 3.94 Mn | n/a |
Financials
|
|||
5 yr Average ROE
|
20.41 % | 19.71 % | 17.42 % |
5yr average Equity Multiplier
|
1.35 | 1.53 | 1.7 |
5yr Average Asset Turnover Ratio
|
0.84 | 0.6 | 0.72 |
5yr Avg Net Profit Margin
|
18.13 % | 21.45 % | 13.94 % |
Price to Book
|
13.43 | 13.6 | 8.25 |
P/E
|
69.01 | 72.11 | 72.22 |
5yr Avg Cash Conversion Cycle
|
-55.2 Days | -131.27 Days | -103.57 Days |
Inventory Days
|
19.62 Days | 2.6 Days | 13.03 Days |
Days Receivable
|
30.92 Days | 8.3 Days | 37.6 Days |
Days Payable
|
64.69 Days | 143.28 Days | 144.74 Days |
5yr Average Interest Coverage Ratio
|
65.11 | 8.11 | 11.6 |
5yr Avg ROCE
|
26.01 % | 21.83 % | 18.91 % |
5yr Avg Operating Profit Margin
|
30.0 % | 41.52 % | 25.91 % |
5 yr average Debt to Equity
|
0.01 | 0.0 | 0.08 |
5yr CAGR Net Profit
|
-4.08 % | 11.11 % | -4.56 % |
5yr Average Return on Assets
|
14.94 % | 12.95 % | 10.32 % |
Shareholdings
|
|||
Promoter Holding
|
71.06 % | 52.63 % | 48.89 % |
Share Pledged by Promoters
|
100.0 % | 0.0 | 1.18 % |
Change in Promoter Holding (3 Yrs)
|
-0.12 % | -2.41 % | -0.9 % |
Change in Mutual Fund Holding (3 Yrs)
|
7.94 % | 10.79 % | 17.05 % |
Thyrocare Tech.
|
Vijaya Diagnostic
|
Metropolis Health.
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Distribution Channel
|
Distribution Channel
|
Distribution Channel
|
Distribution Channel
|
Capex
|
Capex
|
-
|
-
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
-
|
Pathology vs Radiology
|
Pathology vs Radiology
|
-
|
-
|
Asset Break-Up
|
Asset Break-Up
|
-
|
Asset Break-Up
|